Smaller cornu ammonis 23/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms

Biological Psychiatry

Volumn 68, Issue 6, 2010, Pages 553-559

  Gold, Stefan M ^a   Kern, Kyle C ^a   O'Connor, Mary Frances ^a   Montag, Michael J ^a   Kim, Aileen ^a   Yoo, Ye S ^a   Giesser, Barbara S ^a   Sicotte, Nancy L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cornu ammonis; cortisol; depression; hippocampus; neurodegeneration; relapsing remitting multiple sclerosis

Indexed keywords

ANTIDEPRESSANT AGENT; BETA INTERFERON; GABAPENTIN; GLATIRAMER; HYDROCORTISONE; MODAFINIL; NATALIZUMAB; OPIATE; SEROTONIN UPTAKE INHIBITOR; STEROID; TOPIRAMATE; TRAZODONE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DISEASE DURATION; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; HYDROCORTISONE RELEASE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBICULUM;

ADULT; ATROPHY; DENTATE GYRUS; DEPRESSION; FEMALE; HIPPOCAMPUS; HUMANS; HYDROCORTISONE; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SALIVA;

EID: 77956178243     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.04.025     Document Type: Article

References (52)

1. R.J. Siegert, and D.A. Abernethy Depression in multiple sclerosis: A review J Neurol Neurosurg Psychiatry 76 2005 469 475
2. A. Feinstein Mood disorders in multiple sclerosis and the effects on cognition J Neurol Sci 245 2006 63 66
3. A. Jonsson, J. Dock, and M.H. Ravnborg Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis Acta Neurol Scand 93 1996 229 235
4. B.G. Vickrey, R.D. Hays, R. Harooni, L.W. Myers, and G.W. Ellison A health-related quality of life measure for multiple sclerosis Qual Life Res 4 1995 187 206
5. D.C. Mohr, D.E. Goodkin, W. Likosky, N. Gatto, K.A. Baumann, and R.A. Rudick Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis Arch Neurol 54 1997 531 533
6. A. Feinstein Multiple sclerosis, depression, and suicide BMJ 315 1997 691 692
7. Goldman The Goldman consensus statement on depression in multiple sclerosis Mult Scler 11 2005 328 337
8. A. Moller, G. Wiedemann, U. Rohde, H. Backmund, and A. Sonntag Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis Acta Psychiatr Scand 89 1994 117 121
9. M.J. Sullivan, B. Weinshenker, S. Mikail, and K. Edgley Depression before and after diagnosis of multiple sclerosis Mult Scler 1 1995 104 108
10. R. Bakshi, D. Czarnecki, Z.A. Shaikh, R.L. Priore, V. Janardhan, Z. Kaliszky, and P.R. Kinkel Brain MRI lesions and atrophy are related to depression in multiple sclerosis Neuroreport 11 2000 1153 1158
11. A. Feinstein, P. Roy, N. Lobaugh, K. Feinstein, P. O'Connor, and S. Black Structural brain abnormalities in multiple sclerosis patients with major depression Neurology 62 2004 586 590
12. M. Zorzon, R. de Masi, D. Nasuelli, M. Ukmar, R.P. Mucelli, and G. Cazzato Depression and anxiety in multiple sclerosis A clinical and MRI study in 95 subjects J Neurol 248 2001 416 421
13. M. Zorzon, R. Zivadinov, D. Nasuelli, M. Ukmar, A. Bratina, and M.A. Tommasi Depressive symptoms and MRI changes in multiple sclerosis Eur J Neurol 9 2002 491 496
14. C.M. Pariante, and S.L. Lightman The HPA axis in major depression: Classical theories and new developments Trends Neurosci 31 2008 464 468
15. P.C. Koolschijn, N.E. van Haren, G.J. Lensvelt-Mulders, H.E. Hulshoff Pol, and R.S. Kahn Brain volume abnormalities in major depressive disorder: A meta-analysis of magnetic resonance imaging studies Hum Brain Mapp 30 2009 3719 3735
16. N.L. Sicotte, K.C. Kern, B.S. Giesser, A. Arshanapalli, A. Schultz, and M. Montag Regional hippocampal atrophy in multiple sclerosis Brain 131 2008 1134 1141
17. J.J. Geurts, I.E. Reuling, H. Vrenken, B.M. Uitdehaag, C.H. Polman, and J.A. Castelijns MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis Magn Reson Med 55 2006 478 483
18. J.J. Geurts, L. Bo, S.D. Roosendaal, T. Hazes, R. Daniels, and F. Barkhof Extensive hippocampal demyelination in multiple sclerosis J Neuropathol Exp Neurol 66 2007 819 827
19. D. Papadopoulos, S. Dukes, R. Patel, R. Nicholas, A. Vora, and R. Reynolds Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis Brain Pathol 19 2009 238 253
20. R.H. Benedict, D. Ramasamy, F. Munschauer, B. Weinstock-Guttman, and R. Zivadinov Memory impairment in multiple sclerosis: Correlation with deep grey matter and mesial temporal atrophy J Neurol Neurosurg Psychiatry 80 2009 201 206
21. M.O. Ziehn, A.A. Avedisian, S. Tiwari-Woodruff, and P.R. Voskuhl Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE Lab Invest 5 2010 774 786 Epub ahead of print 90, Nos.
22. C. Heesen, S.M. Gold, I. Huitinga, and J.M. Reul Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosisa review Psychoneuroendocrinology 32 2007 604 618
23. M.C. Ysrraelit, M.I. Gaitan, A.S. Lopez, and J. Correale Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis Neurology 71 2008 1948 1954
24. S.M. Gold, D.C. Mohr, I. Huitinga, P. Flachenecker, E.M. Sternberg, and C. Heesen The role of stress-response systems for the pathogenesis and progression of MS Trends Immunol 26 2005 644 652
25. C.E. Gee, P. Benquet, O. Raineteau, L. Rietschin, S.W. Kirbach, and U. Gerber NMDA receptors and the differential ischemic vulnerability of hippocampal neurons Eur J Neurosci 23 2006 2595 2603
26. Q. Wang, S. Yu, A. Simonyi, G.Y. Sun, and A.Y. Sun Kainic acid-mediated excitotoxicity as a model for neurodegeneration Mol Neurobiol 31 2005 3 16
27. C.D. Conrad Chronic stress-induced hippocampal vulnerability: The glucocorticoid vulnerability hypothesis Rev Neurosci 19 2008 395 411
28. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.P. Hartung, and F.D. Lublin Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis Ann Neurol 50 2001 121 127
29. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
30. A.T. Beck, G. Brown, and R.A. Steer Beck Depression Inventory II Manual 1996 Psychological Corporation San Antonio, TX
31. A.T. Beck, and R.A. Steer Beck Anxiety Inventory 1990 Psychological Corporation San Antonio, TX
32. S.M. Smith, Y. Zhang, M. Jenkinson, J. Chen, P.M. Matthews, A. Federico, and N. De Stefano Accurate, robust, and automated longitudinal and cross-sectional brain change analysis Neuroimage 17 2002 479 489
33. S.M. Smith, M. Jenkinson, M.W. Woolrich, C.F. Beckmann, T.E. Behrens, and H. Johansen-Berg Advances in functional and structural MR image analysis and implementation as FSL Neuroimage 23 suppl 1 2004 S208 S219
34. J.D. Bremner, M. Narayan, E.R. Anderson, L.H. Staib, H.L. Miller, and D.S. Charney Hippocampal volume reduction in major depression Am J Psychiatry 157 2000 115 118
35. E. Mervaala, J. Fohr, M. Kononen, M. Valkonen-Korhonen, P. Vainio, and K. Partanen Quantitative MRI of the hippocampus and amygdala in severe depression Psychol Med 30 2000 117 125
36. M. Ballmaier, K.L. Narr, A.W. Toga, V. Elderkin-Thompson, P.M. Thompson, and L. Hamilton Hippocampal morphology and distinguishing late-onset from early-onset elderly depression Am J Psychiatry 165 2008 229 237
37. J.A. Posener, L. Wang, J.L. Price, M.H. Gado, M.A. Province, and M.I. Miller High-dimensional mapping of the hippocampus in depression Am J Psychiatry 160 2003 83 89
38. R.E. Gonsette Oxidative stress and excitotoxicity: A therapeutic issue in multiple sclerosis? Mult Scler 14 2008 22 34
39. R.M. Sapolsky, H. Uno, C.S. Rebert, and C.E. Finch Hippocampal damage associated with prolonged glucocorticoid exposure in primates J Neurosci 10 1990 2897 2902
40. B.S. McEwen Stress and hippocampal plasticity Annu Rev Neurosci 22 1999 105 122
41. K. Dinkel, A. MacPherson, and R.M. Sapolsky Novel glucocorticoid effects on acute inflammation in the CNS J Neurochem 84 2003 705 716
42. R.M. Sapolsky Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders Arch Gen Psychiatry 57 2000 925 935
43. F.A. Henn, and B. Vollmayr Neurogenesis and depression: Etiology or epiphenomenon? Biol Psychiatry 56 2004 146 150
44. B. Czeh, and P.J. Lucassen What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 257 2007 250 260
45. B.S. McEwen Interacting mediators of allostasis and allostatic load: Towards an understanding of resilience in aging Metabolism 52 2003 10 16
46. Y.I. Sheline, M.H. Gado, and H.C. Kraemer Untreated depression and hippocampal volume loss Am J Psychiatry 160 2003 1516 1518
47. R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, and K.W. Kelley From inflammation to sickness and depression: When the immune system subjugates the brain Nat Rev Neurosci 9 2008 46 56
48. S.M. Gold, and M.R. Irwin Depression and immunity: Inflammation and depressive symptoms in multiple sclerosis Immunol Allergy Clin North Am 29 2009 309 320
49. F. Zellini, G. Niepel, C.R. Tench, and C.S. Constantinescu Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis Mult Scler 15 2009 1442 1449
50. I. Huitinga, C.J. De Groot, P. Van der Valk, W. Kamphorst, F.J. Tilders, and D.F. Swaab Hypothalamic lesions in multiple sclerosis J Neuropathol Exp Neurol 60 2001 1208 1218
51. M.J. Sullivan, B. Weinshenker, S. Mikail, and S.R. Bishop Screening for major depression in the early stages of multiple sclerosis Can J Neurol Sci 22 1995 228 231
52. J.J. Prisciandaro, and J.E. Roberts A comparison of the predictive abilities of dimensional and categorical models of unipolar depression in the national comorbidity survey Psychol Med 39 2009 1087 1096